Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hidde Ploegh
Whitehead Institute for Biomedical Res, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
121 Bio LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
How the financial interests relate to the funded research identified above and the basis for the Institution's determination that the financial interests conflicts with such research: Dr. Ploegh is a founder of and consultant to 121Bio, a company founded on the basis of technology developed in the Ploegh Laboratory and licensed to the company. The interests of the company overlap with the research subject matter of the NIH funded award referenced above. A management plan is required to assure that Dr. Ploegh's relationship with 121Bio will not influence the integrity of the research, as the results of the research would fall under the rights granted in the License Agreement to the company.
Sortase-mediated protein engineering for the study of host-pathogen interactions
The present application has as its main goals to visualize aspects of an immune response that have previously been beyond reach. We shall study the behavior on a nanoscale of the antigen specific receptor on B cells, and at the other end of the extreme, we shall visualize an ongoing immune response non- invasively in intact mice using new tools developed in the preceding funding period.
Filed on March 10, 2015.
Tell us what you know about Hidde Ploegh's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Hidde Ploegh filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Hidde Ploegh | Whitehead Institute for Biomedical Res | Conflict of Interest | 121 Bio LLC | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.